Thank You! More Brews in 2014
Thank you to all of our brewers and their patrons for making the inaugural Ales for ALS™ a success! Funds are still coming in, we expect to approach nearly $150,000 in total fundraising for this first year. On behalf of the Smith, Hanses and Reich families, thank you each for your support. We will be collecting information and making announcements about the 2014 installment of Ales for ALS™ soon.
Target Brew Time: June / July 2014
Loftus Ranches and Hopunion have created Ales for ALS to support a very worthy cause – ALS research. They have offered participating brewers access to a proprietary hop blend, free of charge, in exchange for participation in Ales for ALS™. Participating brewers are brewing special beers with these hops and will donate a portion of the sales to ALS TDI, the world's leader in ALS research.
What is ALS? (AKA: Lou Gehrig's Disease)
Amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) is a progressive neurodegenerative disease that leads to
due to the death of motor neurons in the spinal cord and brain.
- There is no known cure for the disease.
- The average person survives only 2-5 years following diagnosis.
- About 5,000 people in the US are diagnosed with ALS each year.
- There are about 30,000 people in the US diagnosed with ALS today.
- The worldwide population of ALS patients is estimated at 450,000.
About ALS Therapy Development Institute
The ALS Therapy Development Institute (ALS TDI) is the world's leading ALS research organization and aims to discover and develop effective treatments and a cure for ALS. Built by and for patients, the Cambridge, MA based drug development institute operates as a 501c3 nonprofit: combining the optimal entrepreneurial practices of a biotechnology and pharmaceutical company with the passion and urgency of a nonprofit mission. For more information, please visit us online at www.als.net.